文献速递神经介入DSA

表面修饰血流导向装置治疗未破裂颅内动脉瘤的RECOAT研究

RECOAT study - Retrospective evaluation of surface-modified and coated flow diverters for the treatment of unruptured intracranial aneurysms.
PubMed 文献 · Neuroradiology · 2026-01-31

本研究回顾性纳入8家神经血管中心511例患者共545个未破裂颅内动脉瘤,评价表面修饰或涂层血流导向装置的安全性与疗效。结果显示血栓栓塞事件发生率为7.8%,总体致残致死率为2.1%,术后6个月完全闭塞率为66%,提示该治疗方式具有较高安全性与有效性。

要点

  • 非囊状动脉瘤形态和使用多枚血流导向装置与血栓栓塞事件相关,报告时应关注此类高风险特征。
  • 表面修饰血流导向装置术后6个月完全闭塞率为66%,6个月充分闭塞率为80%。
  • 血栓栓塞事件中以轻微缺血事件为主(3.9%),主要缺血事件仅1.7%。

核心结论

  • 表面修饰或涂层血流导向装置治疗未破裂颅内动脉瘤具有较高安全性与有效性,栓塞并发症发生率较低,闭塞效果良好。
  • 表面修饰是否带来明确临床获益仍需通过比较性研究进一步证实。

研究设计与样本

  • 多中心回顾性研究,纳入8家神经血管中心接受表面修饰或涂层血流导向装置治疗的未破裂颅内动脉瘤患者。
  • 共511例患者545个动脉瘤,平均动脉瘤大小8.2±5.5 mm,12%位于后循环,14%为非囊状形态。
  • 涉及的装置包括Pipeline Vantage、Pipeline Flex with Shield Technology、FRED X、p48/64 HPC、Derivo Embolization Device及DED 2heal。

关键影像表现/征象

  • 非囊状动脉瘤形态与血栓栓塞事件显著相关(p=0.014),使用多枚血流导向装置亦与血栓栓塞事件相关(p=0.025)。
  • 515例手术中26例(5%)使用多枚血流导向装置,76例(15%)联合弹簧圈栓塞。

诊断标准与关键数值

  • 术后6个月完全闭塞率为66%(196/297),充分闭塞率为80%(238/297)。
  • 术后12个月完全闭塞率为70%(64/92),充分闭塞率为85%(78/92)。
  • 血栓栓塞事件发生率为7.8%(40例),包括主要缺血事件1.7%(9例)、轻微缺血事件3.9%(20例)、无症状或技术性事件2.1%(11例)。
  • 出血事件发生率为1.0%(5例),其中3例有症状。
  • 总体致残致死率为2.1%(11/515)。

临床应用与阅片要点

  • 阅片报告时应关注动脉瘤形态是否呈非囊状,非囊状形态患者术后血栓栓塞风险升高。
  • 对于需使用多枚血流导向装置的病例,应提示血栓栓塞事件风险可能增加。
  • 随访血管造影评估时可采用完全闭塞与充分闭塞分级进行疗效判定。

局限性

  • 本研究为回顾性设计,存在回顾性偏倚风险。
  • 各中心使用的装置类型不同,且未设对照组,无法证实表面修饰本身带来的临床获益,需比较性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Surface modifications may improve procedural safety of flow diverter (FD) treatment, but larger studies are rare. This multicenter study aims to evaluate the safety and efficacy of unruptured aneurysm treatment with surface-modified and coated FDs.

METHODS: Patients treated with the following FDs at 8 neurovascular centers were retrospectively reviewed: Pipeline Vantage Embolization Device, Pipeline Flex with Shield Technology, FRED X, p48/64 HPC, Derivo Embolization Device (DED), and DED 2heal. Aneurysm characteristics, procedural details, and angiographic results were evaluated in detail.

RESULTS: A total of 511 patients with 545 aneurysms were included (mean aneurysm size: 8.2 ± 5.5 mm, 12% posterior circulation, 14% non-saccular morphology). Multiple FDs were used in 26/515 (5%) procedures and adjunctive coiling in 76 (15%). Thromboembolic events occurred in 40 (7.8%) cases, including 9 (1.7%) major ischemic events, 20 (3.9%) minor ischemic events and 11 (2.1%) asymptomatic/technical events. Non-saccular aneurysm morphology (p = 0.014) and use of multiple FDs (p = 0.025) favored thromboembolic events. Hemorrhagic events occurred in 5 (1.0%) cases, of which 3 were symptomatic. The combined morbidity and mortality rate was 11/515 (2.1%). Complete and adequate occlusion rates were 66% (196/297) and 80% (238/297) at 6 months, respectively, and 70% (64/92) and 85% (78/92) at 12 months, respectively.

CONCLUSION: The present study demonstrates high safety and efficacy for coated or surface-modified FDs. Whether the surface modifications confer a clinical benefit needs to be addressed in comparative studies.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Goertz, Hohenstatt, Vollherbst, et al. RECOAT study - Retrospective evaluation of surface-modified and coated flow diverters for the treatment of unruptured intracranial aneurysms. Neuroradiology. 2026. PMID: 41619008. doi:10.1007/s00234-025-03873-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。